US FDA Reviews Emergent Biosolutions’ OTC Opioid Overdose Drug
The over-the-counter (OTC) nasal spray by Emergent Biosolutions to treat suspected opioid overdose will be subject to priority review by the US Food and Drug Administration (FDA). Emergent Biosolutions has been trying to get approval from the US Food and Drug Administration (FDA) to let them sell Narcan, a nasal spray that is already approved […]
Continue Reading